Literature DB >> 23311565

Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia.

Edison I O Vidal, Fernanda B Fukushima, Adriana P Valle, Paulo J F Villas Boas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23311565     DOI： 10.1111/jgs.12058

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  8 in total

Review 1.  A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.

Authors:  Giulia Ambrosi; Silvia Cerri; Fabio Blandini
Journal:  J Neural Transm (Vienna)       Date:  2014-01-01       Impact factor: 3.575

Review 2.  Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?

Authors:  Albert Y Hung; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-12

Review 4.  Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments.

Authors:  Panagiotis Bargiotas; Spyridon Konitsiotis
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-22       Impact factor: 2.570

Review 5.  Current Nondopaminergic Therapeutic Options for Motor Symptoms of Parkinson's Disease.

Authors:  Juan-Juan Du; Sheng-Di Chen
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

Review 6.  Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.

Authors:  Zsófia Majláth; Nóra Török; József Toldi; László Vécsei
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 7.  NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.

Authors:  Brigitte Vanle; William Olcott; Jaime Jimenez; Luma Bashmi; Itai Danovitch; Waguih William IsHak
Journal:  Transl Psychiatry       Date:  2018-06-15       Impact factor: 6.222

8.  Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism.

Authors:  Masatoshi Ogawa; Yu Zhou; Ryosuke Tsuji; Jiro Kasahara; Satoshi Goto
Journal:  Front Neurol       Date:  2019-12-05       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.